The Use of Oral Naloxone to Prevent Post Spinal Fusion Ileus
| Status: | Recruiting |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/4/2019 |
| Start Date: | January 2, 2018 |
| End Date: | March 2020 |
| Contact: | Kevin Swong, MD |
| Email: | knswong@gmail.com |
| Phone: | 8158306957 |
Postoperative ileus and opioid induced constipation are well-known post-operative
complications. Previously, research has shown that using peripherally acting opioid
antagonists can help alleviate the condition. There has not been a prospective study to
investigate whether use of peripherally acting opioid antagonists are effective in preventing
post-operative ileus in patients having spinal fusion surgeries.
complications. Previously, research has shown that using peripherally acting opioid
antagonists can help alleviate the condition. There has not been a prospective study to
investigate whether use of peripherally acting opioid antagonists are effective in preventing
post-operative ileus in patients having spinal fusion surgeries.
Post operative ileus is a well-known complication following spinal fusion surgery. There has
been some literature to demonstrate the safety and efficacy of oral naloxone to decrease the
time to bowel movements after gastrointestinal surgery, to date, there have been no studies
within the spine fusion literature to investigate oral naloxone's effects on the time to
bowel movements.
The aim of the present study is to use the previously established protocols and doses
established in the gastrointestinal literature to see whether oral naloxone can decrease the
time to first bowel movements.
been some literature to demonstrate the safety and efficacy of oral naloxone to decrease the
time to bowel movements after gastrointestinal surgery, to date, there have been no studies
within the spine fusion literature to investigate oral naloxone's effects on the time to
bowel movements.
The aim of the present study is to use the previously established protocols and doses
established in the gastrointestinal literature to see whether oral naloxone can decrease the
time to first bowel movements.
Inclusion Criteria:
- Patients will be included if they are having an in-patient spinal fusion procedure,
are 18 years or older, post and post-operative pain control plan includes opioid
medications.
Exclusion Criteria:
- Pregnancy, age < 18, nursing, or documented allergy to naloxone
We found this trial at
1
site
Click here to add this to my saved trials
